ELENA
GALVE CALVO
Hospital General Universitario Gregorio Marañón
Madrid, EspañaHospital General Universitario Gregorio Marañón-ko ikertzaileekin lankidetzan egindako argitalpenak (2)
2022
2018
-
Cost-effectiveness analysis of ribociclib versus palbociclib in the first-line treatment of HR+/ HER2– advanced or metastatic breast cancer in Spain
ClinicoEconomics and Outcomes Research, Vol. 10, pp. 773-790